Catalyst Wire Dossier Catalyst Wire Dossier

DORAVIRINE-based regimen

doravirine-based regimen
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for DORAVIRINE-based regimen, covering 2023-08-03 to 2023-08-03. Get the full timeline:

Most recent: Clinical Trial Update: DORA: A Doravirine-based First-line Antiretroviral Therapy for Women of Reproductive Potential Living With HIV [Phase 3]

See pricing